Tumor necrosis factor-α down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway

Free Radical Biology and Medicine

Volumn 41, Issue 5, 2006, Pages 709-721

  Afonso, Valéry ^a,b   Santos, Guilherme ^a,b   Collin, Pascal ^a,b   Khatib, Abdel Majid ^c   Mitrovic, Dragoslav R ^a,b   Lomri, Noureddine ^d   Leitman, Dale C ^e   Lomri, Abderrahim ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE CERGY PONTOISE   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AP 1; JNK; Promoter; SOD1; TNF ; Transcription

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MESSENGER RNA; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; DNA BINDING; ENZYME REPRESSION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BASE SEQUENCE; DOWN-REGULATION; HUMANS; MAP KINASE KINASE 4; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 33746723468     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.05.014     Document Type: Article

References (70)

1. Taille C., El-Benna J., Lanone S., Boczkowski J., and Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J. Biol. Chem. 280 (2005) 25350-25360
2. Roos D., De Boer M., Kuribayashi F., Meischi C., Weening R.S., Segal A.W., Ahlin A., Nemet K., Hossle J.P., Bernatowska-Matusskiewicz E., and Middleton-Price H. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87 (1996) 1663-1681
3. Lin Y., Berg A.H., Iyengar P., Lam T.K., Giacca A., Combs T.P., Rajala M.W., Du X., Rollman B., Li W., Hawkins M., Barzilai N., Rhodes C.J., Fantus I.G., Brownlee M., and Scherer P.E. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 280 (2005) 4617-4626
4. Palacino J.J., Sagi D., Goldberg M.S., Krauss S., Motz C., Wacker M., Klose J., and Shen J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279 (2004) 18614-18622
5. Tiku M.L., Shah R., and Allison G.T. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J. Biol. Chem. 275 (2000) 20069-20076
6. Reliene R., Fischer E., and Schiestl R.H. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res. 64 (2004) 5148-5153
7. Liu D., Wen J., Liu J., and Li L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J. 13 (1999) 2318-2328
8. Mody N., Parhami F., Sarafian T.A., and Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med. 31 (2001) 509-519
9. 2-.), superoxide dismutases, and related matters. J. Biol. Chem. 272 (1997) 18515-18517
10. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
11. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18 (1998) 3241-3250
12. Owens T., Wekerle H., and Antel J. Genetic models for CNS inflammation. Nat. Med. 7 (2001) 161-166
13. Beutler B.A. The role of tumor necrosis factor in health and disease. J. Rheumatol. 26 (1999) 16-21
14. Sarkar A., Sreenivasan Y., Ramesh G.T., and Manna S.K. Beta-D-glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis. J. Biol. Chem. 279 (2004) 33768-33781
15. Medina S., Martinez M., and Hernanz A. Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine and beta-amyloid peptide 1-42. Free Radic. Res. 36 (2002) 1179-1184
16. Ma Q., and Kinneer K. Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages. J. Biol. Chem. 277 (2002) 2477-2484
17. Churg A. Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species. Free Radic. Biol. Med. 34 (2003) 1230-1235
18. Nathan I., Dizdaroglu M., Bernstein L., Junker U., Lee C., Muegge K., and Durum S.K. Induction of oxidative DNA damage in U937 cells by TNF or anti-Fas stimulation. Cytokine 12 (2000) 881-887
19. De Nadai C., Sestili P., Cantoni O., Lievremont J.P., Sciorati C., Barsacchi R., Moncada S., Meldolesi J., and Clementi E. Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide. Proc. Natl. Acad. Sci. USA 97 (2000) 5480-5485
20. Sakashita A., Epstein C.J., Carlson E., and Koeffler H. P Hematopoietic progenitor cells of transgenic mice with increased copper/zinc-superoxide dismutase activity are resistant to tumor necrosis factor. J. Cell. Physiol. 160 (1994) 233-238
21. Lehmann T.G., Wheeler M.D., Froh M., Schwabe R.F., Bunzendahl H., Samulski R.J., Lemasters J.J., Brenner D.A., and Thurman R.G. Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat. Transplantation 76 (2003) 28-37
22. Wheeler M.D., Katuna M., Smutney O.M., Froh M., Dikalova A., Mason R.P., Samulski R.J., and Thurman R.G. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum. Gene Ther. 12 (2001) 2167-2177
23. Wheeler M.D., Kono H., Yin M., Rusyn I., Froh M., Connor H.D., Mason R.P., Samulski R.J., and Thurman R.G. Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats. Gastroenterology 120 (2001) 1241-1250
24. Wheeler M.D., and Thurman R.G. Up-regulation of CD14 in liver caused by acute ethanol involves oxidant-dependent AP-1 pathway. J. Biol. Chem. 278 (2003) 8435-8441
25. Lin S.J., Shyue S.K., Hung Y.Y., Chen Y.H., Ku H.H., Chen J.W., Tam K.B., and Chen Y.L. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 334-340
26. Chovolou Y., Watjen W., Kampkotter A., and Kahl R. Resistance to tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis in rat hepatoma cells expressing TNF-alpha is linked to low antioxidant enzyme expression. J. Biol. Chem. 278 (2003) 29626-29632
27. Marikovsky M., Ziv V., Nevo N., Harris-Cerruti C., and Mahler O. Cu/Zn superoxide dismutase plays important role in immune response. J. Immunol. 170 (2003) 2993-3001
28. Rogers R.J., Monnier J.M., and Nick H.S. Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-to-nucleus signaling, whereas interleukin-1beta utilizes an alternative pathway. J. Biol. Chem. 276 (2001) 20419-20427
29. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
30. Young A.P., and Longmore G.D. Ras protects Rb family null fibroblasts from cell death: a role for AP-1. J. Biol. Chem. 279 (2004) 10931-10938
31. Minc E., de Coppet P., Massoni P., Thiery L., Dutertre S., Amor-Guéret M., and Jaulin C. The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites. J. Biol. Chem. 274 (1999) 503-509
32. Tzagarakis-Foster C., Geleziunas R., Lomri A., An J., and Leitman D.C. Estradiol represses human T-cell leukemia virus type 1 Tax activation of tumor necrosis factor-alpha gene transcription. J. Biol. Chem. 277 (2002) 44772-44777
33. Udvadia A.J., Rogers K.T., Higgins P.D., Murata Y., Martin K.H., Humphrey P.A., and Horowitz J.M. Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc. Natl. Acad. Sci. USA 90 (1993) 3265-3269
34. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
35. Aggarwal B.B., Kumar A., and Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23 (2003) 363-398
36. Han S.S., Keum Y.S., Seo H.J., and Surh Y.J. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J. Biochem. Mol. Biol. 31 (2002) 337-342
37. Jobin C., Bradham C.A., Russo M.P., Juma B., Narula A.S., Brenner D.A., and Sartor R.B. Curcumin blocks cytokine-mediated NF-kB activation and proinflammatory gene expression by inhibiting inhibitory factor I-kB kinase activity. J. Immunol. 163 (1999) 3474-3483
38. Chen Y.R., Wang W., Kong A.N., and Tan T.H. Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J. Biol. Chem. 273 (1998) 1769-1775
39. Hemnani T., and Parihar M.S. Reactive oxygen species and oxidative DNA damage. Ind. J. Physiol. Pharmacol. 42 (1998) 440-452
40. Grisham M.B., Granger D.N., and Lefer D.J. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic. Biol. Med. 25 (1998) 404-433
41. Janssen-Heininger Y.M.W., Poynter M.E., and Baeuerle P.A. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic. Biol. Med. 28 (2000) 1317-1327
42. Meier B., Radeke H.H., Selle S., Younes M., Sies H., Resch K., and Habermehl G.G. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem. J. 263 (1989) 539-545
43. Wong G.H.W., and Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242 (1988) 941-944
44. Woo C.H., Eom Y.W., Yoo M.H., You H.J., Han H.J., Song W.K., Yoo Y.J., Chun J.S., and Kim J.H. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J. Biol. Chem. 275 (2000) 32357-32362
45. Chandel N.S., Schumacker P.T., and Arch R.H. Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J. Biol. Chem. 276 (2001) 42728-42736
46. Vlahopoulos S., Boldogh I., Casola A., and Brasier A.R. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94 (1999) 1878-1889
47. Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., Kojima Y., Piao J.H., Yagita H., Okumura K., Doi T., and Nakano H. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22 (2003) 3898-3909
48. O'Donnell V.B., Spycher S., and Azzi A. Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-alpha-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem. J. 310 (1995) 133-141
49. Lee S.B., Cho E.S., Yang H.S., Kim H., and Um H.D. Serum withdrawal kills U937 cells by inducing a positive mutual interaction between reactive oxygen species and phosphoinositide 3-kinase. Cell Signal. 17 (2005) 197-204
50. Israel N., Gougerot-Pocidalo M.A., Aillet F., and Virelizier J.L. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149 (1992) 3386-3393
51. Manna S.K., Mukhopadhyay A., and Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164 (2000) 6509-6519
52. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
53. Kelly K.A., Hill M.R., Youkhana K., Wanker F., and Gimble J.M. Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect. Immun. 62 (1994) 3122-3128
54. Harman D. The aging process: major risk factor for disease and death. Proc. Natl. Acad. Sci. USA 88 (1991) 5360-5363
55. Moodie F.M., Marwick J.A., Anderson C.S., Szulakowski P., Biswas S.K., Bauter M.R., Kilty I., and Rahman I. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J. 18 (2004) 1897-1899
56. Lee K.H., and Choi E.M. Biochanin A stimulates osteoblastic differentiation and inhibits hydrogen peroxide-induced production of inflammatory mediators in MC3T3-E1 cells. Biol. Pharm. Bull. 28 (2005) 1948-1953
57. Marklund S.L. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J. Biol. Chem. 267 (1992) 6696-6701
58. Stralin P., and Marklund S.L. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 151 (2000) 433-441
59. Brady T.C., Chang L.Y., Day B.J., and Crapo J.D. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-kappa B activation. Am. J. Physiol. 273 (1997) L1002-L1006
60. Seo S.J., Kim H.T., Cho G., Rho H.M., and Jung G. Sp1 and C/EBP-related factor regulate the transcription of human Cu/Zn SOD gene. Gene 178 (1996) 177-180
61. Karube-Harada A., Sugino N., Kashida S., Takiguchi S., Takayama H., Yamagata Y., Nakamura Y., and Kato H. Induction of manganese superoxide dismutase by tumour necrosis factor-alpha in human endometrial stromal cells. Mol. Hum. Reprod. 7 (2001) 1065-1072
62. Gilbert L., He X., Farmer P., Rubin J., Drissi H., van Wijnen A.J., Lian J.B., Stein G.S., and Nanes M.S. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J. Biol. Chem. 277 (2002) 2695-2701
63. Verrecchia F., Tacheau C., Erwin F., Wagner E.F., and Mauviel A. A central role for the jnk pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-β-driven SMAD3/4-specific gene expression. J. Biol. Chem. 278 (2003) 1585-1593
64. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11 (2001) 372-377
65. Rojo A.I., Salinas M., Martin D., Perona R., and Cuadrado A. Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J. Neurosci. 24 (2004) 7324-7334
66. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., and Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 (1996) 403-414
67. Rohlff C., Ahmad S., Borellini F., Lei J., and Glazer R.I. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J. Biol. Chem. 272 (1997) 21137-21141
68. Armstrong S.A., Barry D.A., Leggett R.W., and Mueller C.R. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem. 272 (1997) 13489-13495
69. Borellini F., Aquino A., Josephs S.F., and Glazer R.I. Increased expression and DNA-binding activity of transcription factor Sp1 in doxorubicin-resistant HL-60 leukemia cells. Mol. Cell. Biol. 10 (1990) 5541-5547
70. Daniel S., Zhang S., DePaoli-Roach A.A., and Kim K.H. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J. Biol. Chem. 271 (1996) 14692-14697